Search results for "Cardiology"

showing 10 items of 6064 documents

Intracoronary Infusion of Thioflavin-S to Study Microvascular Obstruction in a Model of Myocardial Infarction

2015

Abstract Introduction and objectives Microvascular obstruction exerts deleterious effects after myocardial infarction. To elucidate the role of ischemia-reperfusion injury on the occurrence and dynamics of microvascular obstruction, we performed a preliminary methodological study to accurately define this process in an in vivo model. Methods Myocardial infarction was induced in swine by means of 90-min of occlusion of the mid left anterior descending coronary artery using angioplasty balloons . Intracoronary infusion of thioflavin-S was applied and compared with traditional intra-aortic or intraventricular instillation. The left anterior descending coronary artery perfused area and microvas…

medicine.medical_specialtySwineUltraviolet RaysSus scrofaMyocardial InfarctionLumen (anatomy)Myocardial Reperfusion InjuryAnterior Descending Coronary ArteryCoronary AngiographyBalloonMicrocirculationCoronary CirculationInternal medicineOcclusionPhotographymedicineAnimalsInfusions Intra-ArterialBenzothiazolesMyocardial infarctionFluorescent Dyesbusiness.industryMicrocirculationGeneral Medicinemedicine.diseaseCoronary VesselsDisease Models AnimalThiazolesCoronary OcclusionCoronary occlusionMicrovesselsCardiologybusinessPerfusionRevista Española de Cardiología (English Edition)
researchProduct

European Society of Hypertension Working Group on Obesity: background, aims and perspectives.

2007

Clinica Medica, University ofMilano-Bicocca, Ospedale San Gerardo, Monza, Milan, ItalyCorrespondence and requests for reprints to Professor Jens Jordan, ChairmanWorking Group on Obesity, Franz Volhard Clinical Research Center, HELIOSKlinikum Berlin and Medical Faculty of the Charite´, Wiltbergstrase 50, 13125Berlin, GermanyTel: +49 30 9417 2220; fax: +49 30 9417 2265; e-mail: jens.jordan@charite.de

medicine.medical_specialtySympathetic Nervous SystemPhysiologybusiness.industryNutritional statusBlood PressureBaroreflexWeight LoSurgeryEuropeAntihypertensive AgentFamily medicineHypertensionWeight LossInternal MedicineMedicineHumansObesityCardiology and Cardiovascular MedicinebusinessAntihypertensive AgentsSocieties MedicalJournal of hypertension
researchProduct

High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid.

2021

Abstract Aims  Whether the association between uric acid (UA) and cardiovascular disease is influenced by some facilitating factors is unclear. The aim of this study was to investigate whether the risk of cardiovascular mortality (CVM) associated with elevated UA was modulated by the level of resting heart rate (HR). Methods and results  Multivariable Cox analyses were made in 19 128 participants from the multicentre Uric acid Right for heArt Health study. During a median follow-up of 11.2 years, there were 1381 cases of CVM. In multivariable Cox models both UA and HR, either considered as continuous or categorical variables were independent predictors of CVM both improving risk discriminat…

medicine.medical_specialtySympathetic nervous systemLongitudinal studyEpidemiologyHeart rate030204 cardiovascular system & hematologyCardiovascular03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineHeart rateSympathetic activityMedicine030212 general & internal medicineRisk factorMortalityProportional hazards modelbusiness.industryHazard ratioConfidence intervalmedicine.anatomical_structurechemistryCardiologyUric acidCardiovascular; Heart rate; Longitudinal study; Mortality; Sympathetic activity; Uric acidLongitudinal studyCardiology and Cardiovascular MedicinebusinessUric acidEuropean journal of preventive cardiology
researchProduct

Renal artery denervation for treating resistant hypertension: Definition of the disease, patient selection and description of the procedure

2012

Arterial hypertension is responsible for a significant burden of cardiovascular morbidity and mortality, worldwide. Although several rational and integrated pharmacological strategies are available, the control of high blood pressure still remains largely unsatisfactory. Failure to achieve effective blood pressure control in treated hypertensive patients may have a substantial impact on individual global cardiovascular risk, since it significantly increases the risk of developing hypertension-related macrovascular and microvascular complications. Arterial hypertension is arbitrarily defined as 'resistant' or 'refractory' when the recommended blood pressure goals (clinic blood pressure below…

medicine.medical_specialtySympathetic nervous systemSettore MED/09 - Medicina InternahypertensionDrug ResistanceFemoral arteryRisk AssessmentNephropathyPharmacotherapyRenal ArteryRisk Factorsmedicine.arteryInternal medicinemedicineInternal MedicineHumansArterial PressureRenal arterySympathectomyrenal artery denervationglobal cardiovascular riskantihypertensive therapyAntihypertensive AgentsSettore MED/14 - NefrologiaDenervationrefractory hypertensiontreatmentbusiness.industryPatient SelectionType 2 Diabetes Mellitusresistant hypertensionmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structureBlood pressureTreatment Outcomeresistant hypertension refractory hypertension renal artery denervation antihypertensive therapy global cardiovascular risk.resistant-hypertension; treatment; hypertensionCardiologyCatheter AblationHypertension treatment; Resistant-hypertension treatment; Antihypertensive Agents; Humans; Hypertension; Patient Selection; Renal Artery; Risk Assessment; Risk Factors; Sympathectomy; Treatment Outcome; Arterial Pressure; Catheter Ablation; Drug Resistance; Internal Medicine; Cardiology and Cardiovascular MedicinebusinessCardiology and Cardiovascular Medicineresistant-hypertension
researchProduct

ESH position paper: renal denervation - an interventional therapy of resistant hypertension

2012

Experts from the European Society of Hypertension prepared this position paper in order to summarize current evidence, unmet needs and practical recommendations on the application of percutaneous transluminal ablation of renal nerves [renal denervation (RDN)] as a novel therapeutic strategy for the treatment of resistant hypertension. The sympathetic nervous activation to the kidney and the sensory afferent signals to the central nervous system represent the targets of RND. Clinical studies have documented that catheter-based RDN decreases both efferent sympathetic and afferent sensory nerve traffic leading to clinically meaningful systolic and diastolic blood pressure (BP) reductions in pa…

medicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemSystolePhysiologyCentral nervous systemCardiologyKidneyNeurosurgical ProceduresRenal ArteryDiastoleInternal medicineInternal MedicinemedicineHumansSystoleIntensive care medicineSocieties MedicalAgedRandomized Controlled Trials as TopicDenervationKidneybusiness.industryresistant hypertensionMiddle AgedDenervationEuropeTreatment OutcomeBlood pressuremedicine.anatomical_structureHypertensionCatheter AblationCardiologyPosition paperRenal denervationCardiology and Cardiovascular MedicinebusinessSensory nerve
researchProduct

0110 : Experimental cerebral ischemia in rats increases myocardial vulnerability to ischemia-reperfusion injury ex vivo

2016

For years, the relationship between cardiac and neurological ischemic events has been mainly attributed to overlapping pathophysiological mechanisms and common risk factors. However, acute stroke may induce dramatic alterations of cardiovascular function. The aim of this work was to evaluate how prior cerebrovascular lesions affect myocardial function in vivo and ex vivo , as well as myocardial vulnerability to ischemic injury. Cerebral embolization was performed in adult Wistar male rats by the injection of microspheres into the left internal carotid artery. Left ventricular function, investigated in vivo using echocardiography (1 hour, 24 hours and 7 days after the embolization), was not …

medicine.medical_specialtySympathetic nervous systemmedicine.medical_treatmentIschemia030204 cardiovascular system & hematologycerebral ischemia03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineHeart ratemedicinecardiovascular diseases030212 general & internal medicineEmbolizationStrokeComputingMilieux_MISCELLANEOUSbusiness.industry[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.disease3. Good healthEpinephrinemedicine.anatomical_structureAnesthesiaCardiologyCardiology and Cardiovascular MedicinebusinessReperfusion injuryEx vivomedicine.drug
researchProduct

The challenge of the volume status assessment in heart failure.

2009

medicine.medical_specialtySystoleBlood volumeDoppler echocardiographyVentricular Dysfunction LeftInternal medicinemedicineIntravascular volume statusVentricular PressureHumansSystoleHeart FailureBlood Volumemedicine.diagnostic_testbusiness.industryDisease progressionmedicine.diseasePrognosisEchocardiography DopplerHeart failureCardiologyVentricular pressureheart failure volume status assessmentDisease ProgressionCardiology and Cardiovascular MedicinebusinessAmerican heart journal
researchProduct

Umbilical artery blood flow velocity waveforms during variable decelerations of the fetal heart rate

1991

Blood flow velocities of the umbilical arteries were measured by Doppler ultrasonography during variable decelerations of the fetal heart rate. The flow velocity waveforms, being normal between uterine contractions, showed either an unchanged flow velocity waveform with an exclusive fetal heart rate effect on end-diastolic velocities or a rapid change to absent and reverse diastolic flow during the decelerations, indicating an abrupt increase in placental resistance with a halt in placental perfusion. Computer-aided reconstruction of the fetal heart rate curve revealed the exact temporal relationship between the reduction of umbilical artery perfusion and deceleration of fetal heart rate. W…

medicine.medical_specialtySystoleDiastoleHemodynamicsUltrasonography PrenatalUmbilical ArteriesUterine ContractionDiastolePregnancyInternal medicinemedicine.arteryHeart ratemedicineHumansUmbilical Cord OcclusionFetusbusiness.industryObstetrics and GynecologyUmbilical arteryBlood flowAnatomyHeart Rate FetalCardiologyFemaleLabor Stage FirstbusinessPerfusionBlood Flow VelocityAmerican Journal of Obstetrics and Gynecology
researchProduct

Morbidity and mortality on combination versus monotherapy in the Systolic Hypertension in Europe Trial

2009

medicine.medical_specialtySystolic hypertensionbusiness.industryEmergency medicinemedicineCardiology and Cardiovascular Medicinemedicine.diseaseIntensive care medicinebusinessInternational Journal of Cardiology
researchProduct

Chronic Administration of Slow-Release Nifedipine Improves Arterial Compliance in Elderly Hypertensives with Systolic Hypertension

1988

medicine.medical_specialtySystolic hypertensionbusiness.industryGeneral Neurosciencemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyCompliance (physiology)History and Philosophy of ScienceNifedipineInternal medicinemedicineCardiologybusinessAdministration (government)medicine.drugAnnals of the New York Academy of Sciences
researchProduct